Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
12.78
-0.78 (-5.75%)
At close: Jan 8, 2026, 4:00 PM EST
13.25
+0.47 (3.68%)
Pre-market: Jan 9, 2026, 8:13 AM EST
Vor Biopharma Employees
Vor Biopharma had 159 employees as of December 31, 2024. The number of employees decreased by 9 or -5.36% compared to the previous year.
Employees
159
Change (1Y)
-9
Growth (1Y)
-5.36%
Revenue / Employee
n/a
Profits / Employee
-$15,405,981
Market Cap
494.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -9 | -5.36% |
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VOR News
- 3 days ago - Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 16 days ago - Vor Bio Appoints RA Capital's Andrew Levin, M.D., Ph.D., and Forbion's Wouter Joustra to Board of Directors - GlobeNewsWire
- 25 days ago - Vor Bio Announces $150 Million Private Placement - GlobeNewsWire
- 2 months ago - Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial - Benzinga
- 2 months ago - Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock - GlobeNewsWire
- 2 months ago - Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock - GlobeNewsWire
- 2 months ago - Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China - GlobeNewsWire